HSPA5
Endoplasmic reticulum chaperone BiP
Also known as: BiP, BIP_HUMAN, GRP78
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P11021
- Gene
- HSPA5
- Ensembl
- ENSG00000044574
- Chromosome
- 9
- Canonical length
- 654 aa
- Protein class
- Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters
- Subcellular location
- Cytosol,Mid piece,Principal piece,End piece,Annulus
- Secretome location
- Intracellular and membrane
- Quaternary structure
- Homooligomer
OverviewNCBI Gene
The protein encoded by this gene is a member of the heat shock protein 70 (HSP70) family. This protein localizes to the lumen of the endoplasmic reticulum (ER) where it operates as a typical HSP70 chaperone involved in the folding and assembly of proteins in the ER and is a master regulator of ER homeostasis. During cellular stress, as during viral infection or tumorogenesis, this protein interacts with the transmembrane stress sensor proteins PERK (protein kinase R-like endoplasmic reticulum kinase), IRE1 (inositol-requiring kinase 1), and ATF6 (activating transcription factor 6) where it acts as a repressor of the unfolded protein response (UPR) and also plays a role in cellular apoptosis and senescence. Elevated expression and atypical translocation of this protein to the cell surface has been reported in viral infections and some types of cancer cells. At the cell surface this protein may facilitate viral attachment and entry to host cells. This gene is a therapeutic target for the treatment of coronavirus diseases and chemoresistant cancers. [provided by RefSeq, Jul 2020]
Canonical amino-acid sequenceUniProt
654 residues, UniProt reviewed canonical sequence.
>P11021|HSPA5
1 MKLSLVAAML LLLSAARAEE EDKKEDVGTV VGIDLGTTYS CVGVFKNGRV EIIANDQGNR
61 ITPSYVAFTP EGERLIGDAA KNQLTSNPEN TVFDAKRLIG RTWNDPSVQQ DIKFLPFKVV
121 EKKTKPYIQV DIGGGQTKTF APEEISAMVL TKMKETAEAY LGKKVTHAVV TVPAYFNDAQ
181 RQATKDAGTI AGLNVMRIIN EPTAAAIAYG LDKREGEKNI LVFDLGGGTF DVSLLTIDNG
241 VFEVVATNGD THLGGEDFDQ RVMEHFIKLY KKKTGKDVRK DNRAVQKLRR EVEKAKRALS
301 SQHQARIEIE SFYEGEDFSE TLTRAKFEEL NMDLFRSTMK PVQKVLEDSD LKKSDIDEIV
361 LVGGSTRIPK IQQLVKEFFN GKEPSRGINP DEAVAYGAAV QAGVLSGDQD TGDLVLLDVC
421 PLTLGIETVG GVMTKLIPRN TVVPTKKSQI FSTASDNQPT VTIKVYEGER PLTKDNHLLG
481 TFDLTGIPPA PRGVPQIEVT FEIDVNGILR VTAEDKGTGN KNKITITNDQ NRLTPEEIER
541 MVNDAEKFAE EDKKLKERID TRNELESYAY SLKNQIGDKE KLGGKLSSED KETMEKAVEE
601 KIEWLESHQD ADIEDFKAKK KELEEIVQPI ISKLYGSAGP PPTGEEDTAE KDELLocalizationUniProt · AlphaFold · HPA
Whether an antibody against HSPA5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 809 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 809 nTPM
- thyroid gland: 648 nTPM
- epididymis: 358 nTPM
- liver: 314 nTPM
- placenta: 293 nTPM
- heart muscle: 277 nTPM
Single-cell type
- epididymal basal cells: 2,675 nCPM
- epididymal principal cells: 2,136 nCPM
- syncytiotrophoblasts: 1,847 nCPM
- plasma cells: 1,403 nCPM
- extravillous trophoblasts: 1,248 nCPM
- pancreatic duct cells: 902 nCPM
Immune cell
- total PBMC: 758 nTPM
- basophil: 457 nTPM
- MAIT T-cell: 391 nTPM
- gdT-cell: 386 nTPM
- classical monocyte: 367 nTPM
- NK-cell: 364 nTPM
Brain region
- white matter: 260 nTPM
- hypothalamus: 184 nTPM
- medulla oblongata: 172 nTPM
- pons: 156 nTPM
- choroid plexus: 153 nTPM
- spinal cord: 151 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about HSPA5.
Disease | ImmuneIEDB
Conditions an epitope on HSPA5 was assayed in.
- rheumatoid arthritis B and T cell
- type 1 diabetes mellitus T cell
- prostate adenocarcinoma B cell
- type 2 diabetes mellitus T cell
- Chagas disease B cell
Disease | AutoantibodyPubMed
Conditions in which antibodies against HSPA5 are reported. Each links to that disease's full target list.
Showing 3 of 5 — disease pages carrying at least 10 antigens.
ReferencesPubMed · IEDB
Publications for HSPA5 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
37 publications
- Blood-Brain Barrier Disruption in Neuroimmunological Disease.
2024 · Int J Mol Sci · RCR 11.5 · 55 citations - Linking cell-surface GRP78 to cancer: From basic research to clinical value of GRP78 antibodies.
2022 · Cancer Lett · RCR 4.7 · 57 citations - Cell surface GRP78: a potential mechanism of therapeutic resistant tumors.
2023 · Cancer Cell Int · RCR 4.4 · 36 citations - GRP78 as a potential therapeutic target in cancer treatment: an updated review of its role in chemoradiotherapy resistance of cancer cells.
2025 · Med Oncol · RCR 4.2 · 12 citations - Blood-brain barrier dysfunction in immuno-mediated neurological diseases.
2018 · Immunol Med · RCR 2.8 · 58 citations
Show 20 more of 37 total
- Prostate cancer cell proliferation in vitro is modulated by antibodies against glucose-regulated protein 78 isolated from patient serum.
2006 · Cancer Res · RCR 2.7 · 130 citations - The 78 kDa glucose-regulated protein (GRP78/BIP) is expressed on the cell membrane, is released into cell culture medium and is also present in human peripheral circulation.
2002 · Biosci Rep · RCR 2.3 · 117 citations - Ligation of cancer cell surface GRP78 with antibodies directed against its COOH-terminal domain up-regulates p53 activity and promotes apoptosis.
2009 · Mol Cancer Ther · RCR 2.1 · 89 citations - GRP78 Antibodies Are Associated With Blood-Brain Barrier Breakdown in Anti-Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorder.
2022 · Neurol Neuroimmunol Neuroinflamm · RCR 1.9 · 26 citations - GRP78 signaling hub a receptor for targeted tumor therapy.
2010 · Adv Genet · RCR 1.9 · 77 citations - Endoplasmic reticulum stress responses in placentation - A true balancing act.
2017 · Placenta · RCR 1.7 · 39 citations - Anti-GRP78 autoantibodies induce endothelial cell activation and accelerate the development of atherosclerotic lesions.
2018 · JCI Insight · RCR 1.7 · 45 citations - Proteomics-based identification of a tumor-associated antigen and its corresponding autoantibody in gastric cancer.
2010 · Oncol Rep · RCR 1.3 · 46 citations - Scratching the Surface-An Overview of the Roles of Cell Surface GRP78 in Cancer.
2022 · Biomedicines · RCR 1.3 · 15 citations - GRP78 antibodies damage the blood-brain barrier and relate to cerebellar degeneration in Lambert-Eaton myasthenic syndrome.
2019 · Brain · RCR 1.1 · 23 citations - Autoantibodies against glucose-regulated protein 78 as serological diagnostic biomarkers in hepatocellular carcinoma.
2012 · Int J Oncol · RCR 1.1 · 36 citations - Autoantibody against Tumor-Associated Antigens as Diagnostic Biomarkers in Hispanic Patients with Hepatocellular Carcinoma.
2022 · Cells · RCR 1 · 11 citations - GRP 78 antibodies are associated with clinical phenotype in neuromyelitis optica.
2019 · Ann Clin Transl Neurol · RCR 1 · 22 citations - Elevation of serum anti-glucose-regulated protein 78 antibodies in neuropsychiatric systemic lupus erythematosus.
2018 · Lupus Sci Med · RCR 1 · 21 citations - Binding of anti-GRP78 autoantibodies to cell surface GRP78 increases tissue factor procoagulant activity via the release of calcium from endoplasmic reticulum stores.
2010 · J Biol Chem · RCR 0.9 · 36 citations - The presence of anti-GRP78 antibodies in the serum of patients with colorectal carcinoma: a potential biomarker for early cancer detection.
2014 · Int J Biol Markers · RCR 0.9 · 26 citations - Increased Serum Levels of Anti-Carbamylated 78-kDa Glucose-Regulated Protein Antibody in Patients with Rheumatoid Arthritis.
2016 · Int J Mol Sci · RCR 0.8 · 19 citations - Autoantibodies against the cell surface-associated chaperone GRP78 stimulate tumor growth via tissue factor.
2017 · J Biol Chem · RCR 0.8 · 21 citations - Circulating GRP78 antibodies from ovarian cancer patients: a promising tool for cancer cell targeting drug delivery system?
2017 · Oncotarget · RCR 0.7 · 18 citations - Changes in oligosaccharide chains of autoantibodies to GRP78 expressed during progression of malignant melanoma stimulate melanoma cell growth and survival.
2011 · Melanoma Res · RCR 0.6 · 21 citations
Reference: B cellIEDB
4 publications
- Towards High-throughput Immunomics for Infectious Diseases: Use of Next-generation Peptide Microarrays for Rapid Discovery and Mapping of Antigenic Determinants.
2015 · Mol Cell Proteomics · RCR 2.6 · 65 citations - Detection of autoantibodies to citrullinated BiP in rheumatoid arthritis patients and pro-inflammatory role of citrullinated BiP in collagen-induced arthritis.
2011 · Arthritis Res Ther · RCR 1.9 · 68 citations - Disordered Antigens and Epitope Overlap Between Anti-Citrullinated Protein Antibodies and Rheumatoid Factor in Rheumatoid Arthritis.
2020 · Arthritis Rheumatol · RCR 1.7 · 30 citations - Cellular immunotherapy study of prostate cancer patients and resulting IgG responses to peptide epitopes predicted from prostate tumor-associated autoantigens.
2013 · J Immunother · RCR 0.2 · 8 citations
Reference: T cellIEDB
6 publications
- Inflammation-Induced Citrullinated Glucose-Regulated Protein 78 Elicits Immune Responses in Human Type 1 Diabetes.
2018 · Diabetes · RCR 2.5 · 68 citations - CD8+ T Cells Variably Recognize Native Versus Citrullinated GRP78 Epitopes in Type 1 Diabetes.
2021 · Diabetes · RCR 1.3 · 23 citations - Immune responses to citrullinated and homocitrullinated peptides in healthy donors are not restricted to the HLA SE shared allele and can be selected into the memory pool.
2023 · Immunology · RCR 0.8 · 6 citations - Autoantigen BiP-Derived HLA-DR4 Epitopes Differentially Recognized by Effector and Regulatory T Cells in Rheumatoid Arthritis.
2015 · Arthritis Rheumatol · RCR 0.7 · 24 citations - CD4+ T Cells From Individuals With Type 1 Diabetes Respond to a Novel Class of Deamidated Peptides Formed in Pancreatic Islets.
2024 · Diabetes · RCR 0.6 · 4 citations
Show 1 more
- Citrullinated glucose-regulated protein 78 is a candidate target for melanoma immunotherapy.
2022 · Front Immunol · RCR 0.5 · 7 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.41
- gnomAD pLI
- 0.77
- gnomAD missense Z
- 4.03
- DepMap mean gene effect
- -1.25
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to glucose starvation
- cellular response to interleukin-4
- cerebellar Purkinje cell layer development
- cerebellum structural organization
- endoplasmic reticulum unfolded protein response
- ER overload response
- ERAD pathway
- IRE1-mediated unfolded protein response
- maintenance of protein localization in endoplasmic reticulum
- negative regulation of apoptotic process
- negative regulation of IRE1-mediated unfolded protein response
- negative regulation of PERK-mediated unfolded protein response
- negative regulation of protein-containing complex assembly
- negative regulation of transforming growth factor beta receptor signaling pathway
- positive regulation of cell migration
- positive regulation of protein ubiquitination
- positive regulation of transcription by RNA polymerase II
- post-translational protein targeting to membrane, translocation
- protein folding in endoplasmic reticulum
- protein refolding
- regulation of IRE1-mediated unfolded protein response
- response to endoplasmic reticulum stress
- substantia nigra development
- regulation of ATF6-mediated unfolded protein response
- regulation of PERK-mediated unfolded protein response
- regulation of protein folding in endoplasmic reticulum
Molecular functions
- ATP binding
- ATP hydrolysis activity
- ATP-dependent protein folding chaperone
- cadherin binding
- calcium ion binding
- enzyme binding
- heat shock protein binding
- misfolded protein binding
- protein domain specific binding
- protein folding chaperone
- protein sequestering activity
- protein serine/threonine kinase inhibitor activity
- protein-folding chaperone binding
- ribosome binding
- ubiquitin protein ligase binding
- unfolded protein binding
Cellular components
- cell surface
- cytoplasm
- cytosol
- endoplasmic reticulum
- endoplasmic reticulum chaperone complex
- endoplasmic reticulum lumen
- endoplasmic reticulum membrane
- endoplasmic reticulum-Golgi intermediate compartment
- extracellular exosome
- focal adhesion
- intracellular membrane-bounded organelle
- melanosome
- membrane
- midbody
- mitochondrion
- nucleus
- plasma membrane
- protein-containing complex
Protein domainsUniProt · Pfam · InterPro
- Heat shock protein 70 family
- Heat shock protein 70, conserved site
- Heat shock protein 70kD, peptide-binding domain superfamily
- Heat shock protein 70kD, C-terminal domain superfamily
- ATPase, nucleotide binding domain
- Hsp70 protein
- Endoplasmic reticulum chaperone BIP, nucleotide-binding domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of HSPA5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HSPA5 as an antibody target. Whether an autoantibody or antibody against HSPA5 could matter depends on whether native HSPA5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HSPA5 is annotated at the cell surface, where native HSPA5 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label HSPA5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...